Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol QNRX
- Company Quoin Pharmaceuticals, Ltd.
- Price $6.12
- Changes Percentage 18.72
- Change 0.965
- Day Low $6.01
- Day High $8.2
- Year High $41.8
- Year Low $3.25
- Market Cap $11,185,006
- Price Avg 50 EMA (D) $4.59
- Price Avg 200 EMA (D) $8.21
- Exchange NASDAQ
- Volume 71,851
- Average Volume 241,722
- Open $7.22
- Previous Close $5.16
- EPS -29.56
- PE -0.19
- Earnings Announcement 2026-11-05 12:00:00
- Shares Outstanding $2,008,080
Company brief: QUOIN PHARMACEUTICALS, LTD. (QNRX )
- Healthcare
- Biotechnology
- Dr. Michael Myers Ph.D.
- https://quoinpharma.com
- US
- N/A
- 08-01-2016
- US74907L3006
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
